Donepezil Market Insights On Growth Drivers, Trends, And Opportunities

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Donepezil Market Projected To Reach By 2030?

The donepezil market has seen a consistent increase in size over recent years. It is anticipated to expand from $1.04 billion in 2025 to $1.09 billion in 2026, with a compound annual growth rate (CAGR) of 4.5%. The expansion observed historically can be attributed to an aging global population, the rising occurrence of Alzheimer’s disease, the widespread acceptance of cholinesterase inhibitors, better rates of dementia diagnosis, and the growth of neurology treatment facilities.

The donepezil market size is anticipated to show consistent growth over the coming years, projected to reach $1.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.5%. This expansion during the forecast period is primarily driven by the increasing global elderly population, greater awareness of early dementia treatment, a growing demand for cost-effective generics, the expansion of home-based cognitive care, and increased healthcare expenditure on neurodegenerative diseases. Significant trends expected during this period include the rising long-term use of donepezil in Alzheimer’s disease management, a growing preference for oral cognitive enhancement therapies, an escalating demand for generic donepezil formulations, the broadening of treatment for mild to moderate Alzheimer’s cases, and an enhanced focus on geriatric neurology care.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21174&type=smp

Which Key Drivers Are Affecting The Donepezil Market Development?

The rising occurrence of Alzheimer’s disease is anticipated to boost the expansion of the donepezil market. Alzheimer’s disease is a progressive neurological condition characterized by the degeneration and death of brain cells, leading to memory impairment, cognitive decline, and behavioral shifts. The increasing number of Alzheimer’s disease cases can be attributed to several factors, such as an aging demographic, population growth, lifestyle choices, an uptick in chronic illnesses, genetic predispositions, and environmental exposures. Donepezil serves as an effective symptomatic therapy for Alzheimer’s disease, enhancing cognitive function and daily living skills by acting on acetylcholine levels in the brain. For instance, in May 2024, a report from the Alzheimer’s Association, a US-based nonprofit organization dedicated to Alzheimer’s care, support, and research, indicated that the population of Americans aged 65 and older diagnosed with Alzheimer’s dementia grew from 6.5 million in 2022 to an estimated 6.9 million in 2024. Thus, the escalating incidence of Alzheimer’s is propelling the growth of the donepezil market.

How Is The Donepezil Market Organized By Segment Classification?

The donepezil market covered in this report is segmented –

1) By Type: 5mg, 10mg, 23mg

2) By Route Of Administration: Oral, Transdermal

3) By Application: Hospitals, Clinics, Drugstore

Which Trends Are Shaping The Donepezil Market?

Leading firms within the donepezil market are prioritizing the creation of sophisticated drug delivery methods, like once-weekly and extended-release transdermal systems, aimed at enhancing patient adherence and lessening treatment-associated discomfort for individuals with Alzheimer’s. These donepezil transdermal systems administer the medication via the skin at a regulated pace, thereby bypassing initial liver metabolism and mitigating the chance of digestive side effects commonly linked with orally administered doses. As an illustration, in March 2024, Corium, Inc., a US-based biopharmaceutical company, unveiled its updated Adlarity formulation, featuring stronger patch adhesion, better skin tolerability, and a more consistent 7-day release profile ensuring continuous therapeutic levels. Corium engineered this improved system to simplify Alzheimer’s treatment, by decreasing the frequency of dosing and fostering better compliance among older adults who find daily oral medication routines challenging.

Who Are The Industry Participants Involved In The Donepezil Market?

Major companies operating in the donepezil market are AbbVie Inc., Pfizer Inc., Teva Pharmaceutical Inc., Intas Pharmaceuticals Ltd., Mylan NV, Sandoz Group AG, Hetero Drugs Ltd., Sun Pharmaceutical Inc., Eisai Co. Ltd., Cipla Ltd., Dr Reddy’s Laboratories, Apotex Inc., H Lundbeck A/S, Zydus Cadila, Amneal Pharmaceuticals LLC, Torrent Pharmaceuticals Ltd, Alkem Laboratories Ltd., Jubilant Pharmova Ltd., Wockhardt Ltd., Luoxin Pharmaceuticals Group

Get The Full Donepezil Market Report:

https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report

Where Is The Donepezil Market Most Concentrated Geographically?

North America was the largest region in the donepezil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the donepezil market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Donepezil Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/donepezil-global-market-report

Browse Through More Reports Similar to the Global Donepezil Market 2026, By The Business Research Company

Dozer Market Report 2026

https://www.thebusinessresearchcompany.com/report/dozer-global-market-report

Omeprazole Market Report 2026

https://www.thebusinessresearchcompany.com/report/omeprazole-global-market-report

Atenolol Market Report 2026

https://www.thebusinessresearchcompany.com/report/atenolol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795